US7828818B2 - Heart septal defect occlusion devices with adjustable length tether adapting to the unique anatomy of the patient - Google Patents

Heart septal defect occlusion devices with adjustable length tether adapting to the unique anatomy of the patient Download PDF

Info

Publication number
US7828818B2
US7828818B2 US11/307,178 US30717806A US7828818B2 US 7828818 B2 US7828818 B2 US 7828818B2 US 30717806 A US30717806 A US 30717806A US 7828818 B2 US7828818 B2 US 7828818B2
Authority
US
United States
Prior art keywords
disc
skeletons
metal mesh
discs
skeleton
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US11/307,178
Other versions
US20060200196A1 (en
Inventor
Shixian Zang
Eirc Zi
Shiwen Lv
Yaoting Feng
Yuehui Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifetech Scientific Shenzhen Co Ltd
Original Assignee
Lifetech Scientific Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifetech Scientific Inc filed Critical Lifetech Scientific Inc
Assigned to LIFETECH SCIENTIFIC INC. reassignment LIFETECH SCIENTIFIC INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FENG, YAOTING, LV, SHIWEN, XIE, YUEHUI, ZANG, SHIXIAN, ZI, ERIC
Publication of US20060200196A1 publication Critical patent/US20060200196A1/en
Priority to US12/927,194 priority Critical patent/US8366743B2/en
Application granted granted Critical
Publication of US7828818B2 publication Critical patent/US7828818B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00592Elastic or resilient implements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00597Implements comprising a membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00615Implements with an occluder on one side of the opening and holding means therefor on the other

Definitions

  • the present invention relates to an occlusion device for treating congenital heart disease, such as patent foramen ovale (PFO), atrial septal defect (ASD), patent ductus arteriosus (PDA) or ventricular septal defect (VSD), etc.
  • PFO patent foramen ovale
  • ASD atrial septal defect
  • PDA patent ductus arteriosus
  • VSD ventricular septal defect
  • Congenital heart diseases include patent foramen ovale (PFO), atrial septal defect (ASD), patent ductus arteriosus (PDA) and ventricular septal defect (VSD), etc.
  • PFO and ASD are openings in the wall between the right atrium and left atrium of the heart thereby creating the possibility that the blood could pass from the right atrium to the left atrium.
  • the defect size of PFO is usually smaller than that of ASD and the defect will not extend perpendicularly to the septal wall, i.e. left atrial septal defect is not concentric with that of the right atrium.
  • the occluder Once the occluder has been placed, it will prevent the thrombus from entering into the left atrium.
  • the atrial septal defect (ASD) is usually larger and requires repair.
  • endocardiac occlusion devices for treating congenital heart diseases. These occluders are delivered to the desired location by a corresponding catheter.
  • the two discs are a whole, they cannot automatically adjust the angle to adapt to the unique anatomy of the patient. Meanwhile, if the left disc is not deployed completely the operation becomes more complicated.
  • the present invention provides a reliable occlusion device with adjustable length tether which can adapt the interseptal length of the device to the unique anatomy of the patient.
  • the two discs can attach to the septal defect closely, so they can improve the closing ability.
  • thrombus can be reduced because its left disc is covered with membranes and operate more easily.
  • the present invention provides an occlusion device where the right disc is made from a double-deck wire mesh with contraction function, and the left disc is made from at least two skeletons covered with membranes, and the two discs are adaptively interlocked together by the skeletons passing through the mesh of the right disc.
  • each skeleton is U shape, and the depths of the U trough are different, so the skeleton can form a plane after being linked together.
  • the skeleton is then covered with membranes to form a disc shape.
  • the left disc is made from several radially-extending skeletons by heat treatment, and covered with membranes, and the center of each skeleton extends radially after overlapping together.
  • each skeleton is spherical shaped and are wrapped by the membranes, and the ends of the right disc are fixed by a tip or a joint, then the right disc undergoes heat treatment. Then the skeletons pass through the mesh near the tip and are overlapped together.
  • the membranes are made from biocompatible materials.
  • the device can adapt to the interseptal length between two discs for the unique anatomy of the patient. Therefore, the two discs may attach to the heart defects closely and increase its closing ability. Moreover, the occlusion device can reduce the thrombus as well as harmful elements because of its left disc being covered with membranes. In addition, the device, which is fission structure, (i.e. its two discs could deploy completely), is easy to operate and increases the closing reliability.
  • FIG. 1 is a schematic representation of a disc which is constructed by skeletons in accordance with the invention.
  • FIG. 2 is a side view of the right disc in accordance with the invention.
  • FIG. 3 is a side view of the skeleton in accordance with the invention.
  • FIG. 4 is a side view of the occlusion device in accordance with the invention.
  • FIG. 5 is an enlarged partial sectional view of part A as shown in FIG. 4 .
  • FIG. 6 is a front view of the occlusion device in accordance with the invention.
  • FIG. 7 and FIG. 8 are alternative embodiments of skeletons.
  • FIG. 9 is a side view of the membrane, which is used to cover the skeletons in accordance with the invention.
  • FIG. 10 is a side view of the skeletons, which have been covered with membranes such as shown in FIG. 9 .
  • FIG. 11 is a schematic representation of a mould, which is used to heat-treat the skeletons.
  • FIG. 12 is a schematic representation of a PFO occluder being released from a delivery catheter.
  • FIG. 13 is a schematic representation of an ASD occluder being released from a delivery catheter.
  • the present invention provides a heart septal defect occlusion device for occluding an anatomical aperture, such as a patent foramen ovale occluder shown in FIG. 4 .
  • the occluder comprises right disc 21 (i.e. metal mesh disc), tip 22 , joint 23 , left disc 1 which is covered with membranes, and membranes 100 , as shown in FIG. 1 and FIG. 9 .
  • the present invention will be described using a PFO occluder as an example.
  • the maximal character of the PFO occluder when compared with those of the above-referenced patents, is that the left disc 1 comprises six skeletons 11 which are spaced apart evenly. And the six skeletons are linked together in the center and form a radial-extending disc. It is possible that the left disc 1 may comprise at least two skeleton 11 as shown in FIG. 3 , and skeleton 11 is made from nitinol wire with shape memory.
  • FIG. 3 The maximal character of the PFO occluder, when compared with those of the above-referenced patents, is that the left disc 1 comprises six skeletons 11 which are spaced apart evenly. And the six skeletons are linked together in the center and form a radial-extending disc. It is possible that the left disc 1 may comprise at least two skeleton 11 as shown in FIG. 3 , and skeleton 11 is made from nitinol wire with shape memory
  • the mould which is used to heat treat skeletons 11 ;
  • the mould includes upper-mould 201 , middle-mould 202 and under-mould 203 and the nitinol wire will be put into the rabbet of the middle-mould 202 .
  • the crystal structure of the nitinol wire can be reset in the austenitic phase, and this will tend to “set” the shape of the device, (i.e., it can keep the shape when it is fixed in the mould).
  • the wire can keep the “set” shape even if cooled, and when the outside force is withdrawn, it can resume its original shape.
  • the middle segment of the skeleton 11 is U shape, and the depth of each U trough is different. By providing different depth U troughs for each skeleton 11 , these skeletons can form a plane after they have been overlapped together.
  • the skeletons 11 are then covered with membranes to form the left disc 1 .
  • the right disc 21 of a PFO occluder uses moulding components. Firstly, the suitable tubular metal mesh of the PFO occluder is formed by weaving or laser carving, then the tubular metal mesh is inserted into the mould and undergoes heat treatment. And, the tip 22 and joint 23 are welded to the disc as shown in FIG. 2 .
  • the skeleton 11 as shown in FIG. 3 is passed through the right disc 21 and near the tip 22 , and then a double-disc structure is formed as shown in FIG. 5 . And as shown in FIG. 6 , the skeletons 11 are spaced apart evenly. Accordingly, these skeletons 11 form a metal disc as shown in FIG. 4 .
  • FIG. 9 illustrates the skeleton 11 with covered membranes 100 .
  • the membranes are made from biocompatible materials. As described above, the spheres of each skeleton are wrapped in the biocompatible materials, so that it can prevent skeleton 11 from puncturing the membranes 100 .
  • Another membrane made by biocompatible material 24 is filled into the right disc 21 .
  • FIG. 7 illustrates another embodiment of a skeleton 11 having a plurality of separate spokes 12 connected (e.g., by welding or clamping) to a central cap 121
  • FIG. 8 illustrates yet another embodiment where a plurality of spokes 13 are attached directly on a tip 22 which can be the same as the tip 22 shown in FIGS. 2 , 4 and 5 .
  • the occlusion device as described above may be extended and put into a catheter, and is delivered to the desired location, then is released.
  • the tapered waist of the device not only ensures its self-centricity but also can reduce the probability of bad occlusion effect resulting from selection error.
  • the left disc 1 which comprises skeletons and membranes, can decrease metal surface areas, thereby decreasing thrombus formation as well as harmful elements.
  • the two discs are both individual components and can deploy completely after release of the occlusion device, and this can avoid forming cucurbit shape and increase the reliability of the desired occlusion.
  • FIG. 12 and FIG. 13 illustrate the deployment process of an FPO occluder and an ASD occluder during operation respectively. Moreover, the occluder has excellent self-centricity because the right disc 21 is close to the left disc 1 .
  • the present invention is also suitable for treating PDA and VSD etc.
  • the only difference from above other occluders is that the metal mesh of the PDA occluder of the present invention will not form a disc, but a “waist”.

Abstract

The present invention relates to heart septal defect occlusion devices with adjustable length tether which can adapt the interseptal length of the device to the unique anatomy of the patient. The right disc as recited in the present invention is made from a double-deck metal mesh with contraction function, and the left disc is made from at least two skeletons covered by membranes. The two discs are active linked together. Because the connection of the two discs has gimbal function and the distance between the two discs may expand and contract suitably, the device can adapt to the unique anatomy of the patient. Therefore the two discs may attach to the heart valves closely and increase its closing ability. Furthermore it can reduce the thrombus and operate more easily.

Description

CROSS REFERENCE TO RELATED APPLICATION
This application claims the benefit of a Chinese patent application No. 20051 0032924.0 (CN), filed on Jan. 28, 2005.
TECHNICAL FIELD
The present invention relates to an occlusion device for treating congenital heart disease, such as patent foramen ovale (PFO), atrial septal defect (ASD), patent ductus arteriosus (PDA) or ventricular septal defect (VSD), etc.
BACKGROUND OF THE INVENTION
Congenital heart diseases include patent foramen ovale (PFO), atrial septal defect (ASD), patent ductus arteriosus (PDA) and ventricular septal defect (VSD), etc. PFO and ASD are openings in the wall between the right atrium and left atrium of the heart thereby creating the possibility that the blood could pass from the right atrium to the left atrium. But the defect size of PFO is usually smaller than that of ASD and the defect will not extend perpendicularly to the septal wall, i.e. left atrial septal defect is not concentric with that of the right atrium. Once the occluder has been placed, it will prevent the thrombus from entering into the left atrium. Furthermore, the atrial septal defect (ASD) is usually larger and requires repair. Currently there are many types endocardiac occlusion devices for treating congenital heart diseases. These occluders are delivered to the desired location by a corresponding catheter.
Mechanical occlusion devices for treating congenital heart diseases have been proposed in the past, some of which are disclosed in Franker et al., Chinese patent application No. 97194488.1; Franker et al., Chinese patent application No. 98808876.2; and Michael et al., Chinese patent application No. 98813470.5. This kind of device includes a support mesh with contractibility and biocompatible materials, and the biocompatible materials are connected to the circumference of the support mesh. The support mesh, which is put into the catheter first, is delivered to the desired location, and then is deployed to close the septal defect. This kind of device is easy to withdraw and has excellent centricity. However, the left disc of this device directly contacts blood, so that it can form thrombus and release harmful metallic elements more easily. Moreover, because the two discs are a whole, they cannot automatically adjust the angle to adapt to the unique anatomy of the patient. Meanwhile, if the left disc is not deployed completely the operation becomes more complicated. In addition, with the existing technique and the operation method, it is very difficult to determine the size and shape of the septal defect precisely, as well as the limit of the waist size, thereby causing many difficulties to physicians, such as selection error, etc. If an oversized device is selected, the occluder will form a cucurbit shape, and result in an imperfect closing effect.
Accordingly, it would be advantageous to provide a reliable occlusion device which can automatically adjust the angle to adapt to the unique anatomy of the patient.
SUMMARY OF THE INVENTION
The present invention provides a reliable occlusion device with adjustable length tether which can adapt the interseptal length of the device to the unique anatomy of the patient. The two discs can attach to the septal defect closely, so they can improve the closing ability. Moreover, thrombus can be reduced because its left disc is covered with membranes and operate more easily.
The present invention provides an occlusion device where the right disc is made from a double-deck wire mesh with contraction function, and the left disc is made from at least two skeletons covered with membranes, and the two discs are adaptively interlocked together by the skeletons passing through the mesh of the right disc.
The middle segment of each skeleton is U shape, and the depths of the U trough are different, so the skeleton can form a plane after being linked together. The skeleton is then covered with membranes to form a disc shape.
The left disc is made from several radially-extending skeletons by heat treatment, and covered with membranes, and the center of each skeleton extends radially after overlapping together.
The two ends of each skeleton are spherical shaped and are wrapped by the membranes, and the ends of the right disc are fixed by a tip or a joint, then the right disc undergoes heat treatment. Then the skeletons pass through the mesh near the tip and are overlapped together. The membranes are made from biocompatible materials.
Furthermore, because the connection of the two discs has gimbal function and the distances between the two discs may expand and contract suitably, the device can adapt to the interseptal length between two discs for the unique anatomy of the patient. Therefore, the two discs may attach to the heart defects closely and increase its closing ability. Moreover, the occlusion device can reduce the thrombus as well as harmful elements because of its left disc being covered with membranes. In addition, the device, which is fission structure, (i.e. its two discs could deploy completely), is easy to operate and increases the closing reliability.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a schematic representation of a disc which is constructed by skeletons in accordance with the invention.
FIG. 2 is a side view of the right disc in accordance with the invention.
FIG. 3 is a side view of the skeleton in accordance with the invention.
FIG. 4 is a side view of the occlusion device in accordance with the invention.
FIG. 5 is an enlarged partial sectional view of part A as shown in FIG. 4.
FIG. 6 is a front view of the occlusion device in accordance with the invention.
FIG. 7 and FIG. 8 are alternative embodiments of skeletons.
FIG. 9 is a side view of the membrane, which is used to cover the skeletons in accordance with the invention.
FIG. 10 is a side view of the skeletons, which have been covered with membranes such as shown in FIG. 9.
FIG. 11 is a schematic representation of a mould, which is used to heat-treat the skeletons.
FIG. 12 is a schematic representation of a PFO occluder being released from a delivery catheter.
FIG. 13 is a schematic representation of an ASD occluder being released from a delivery catheter.
DETAILED DESCRIPTION OF THE INVENTION
The present invention provides a heart septal defect occlusion device for occluding an anatomical aperture, such as a patent foramen ovale occluder shown in FIG. 4. The occluder comprises right disc 21 (i.e. metal mesh disc), tip 22, joint 23, left disc 1 which is covered with membranes, and membranes 100, as shown in FIG. 1 and FIG. 9.
The present invention will be described using a PFO occluder as an example. The maximal character of the PFO occluder, when compared with those of the above-referenced patents, is that the left disc 1 comprises six skeletons 11 which are spaced apart evenly. And the six skeletons are linked together in the center and form a radial-extending disc. It is possible that the left disc 1 may comprise at least two skeleton 11 as shown in FIG. 3, and skeleton 11 is made from nitinol wire with shape memory. FIG. 11 illustrates the mould which is used to heat treat skeletons 11; the mould includes upper-mould 201, middle-mould 202 and under-mould 203 and the nitinol wire will be put into the rabbet of the middle-mould 202. By heating the nitinol wire above a certain phase transition temperature, the crystal structure of the nitinol wire can be reset in the austenitic phase, and this will tend to “set” the shape of the device, (i.e., it can keep the shape when it is fixed in the mould). Except for an outside force, the wire can keep the “set” shape even if cooled, and when the outside force is withdrawn, it can resume its original shape. The middle segment of the skeleton 11 is U shape, and the depth of each U trough is different. By providing different depth U troughs for each skeleton 11, these skeletons can form a plane after they have been overlapped together. The skeletons 11 are then covered with membranes to form the left disc 1. The right disc 21 of a PFO occluder uses moulding components. Firstly, the suitable tubular metal mesh of the PFO occluder is formed by weaving or laser carving, then the tubular metal mesh is inserted into the mould and undergoes heat treatment. And, the tip 22 and joint 23 are welded to the disc as shown in FIG. 2.
After the two ends have been welded into spheres respectively, the skeleton 11 as shown in FIG. 3 is passed through the right disc 21 and near the tip 22, and then a double-disc structure is formed as shown in FIG. 5. And as shown in FIG. 6, the skeletons 11 are spaced apart evenly. Accordingly, these skeletons 11 form a metal disc as shown in FIG. 4.
The two sides of the left disc 1 are covered with membranes 100 as shown in FIG. 9, and FIG. 10 illustrates the skeleton 11 with covered membranes 100. The membranes are made from biocompatible materials. As described above, the spheres of each skeleton are wrapped in the biocompatible materials, so that it can prevent skeleton 11 from puncturing the membranes 100. Another membrane made by biocompatible material 24 is filled into the right disc 21.
As described above, the overlapping point of left disc 1 is passed through right disc 21, and the connection between the two discs has a gimbal function. Furthermore, the two discs have a trend of shrinking toward the inside, and the occlusion device may swing randomly, i.e., the left disc 1 and right disc 21 may be parallel or be angled. Accordingly, the device can adapt to the unique anatomy in a patient, and the two discs can be attached to the defect closely. Additionally, alternative structure and assembly of the skeleton 11 are shown in FIG. 7 and FIG. 8. FIG. 7 illustrates another embodiment of a skeleton 11 having a plurality of separate spokes 12 connected (e.g., by welding or clamping) to a central cap 121, while FIG. 8 illustrates yet another embodiment where a plurality of spokes 13 are attached directly on a tip 22 which can be the same as the tip 22 shown in FIGS. 2, 4 and 5.
The occlusion device as described above may be extended and put into a catheter, and is delivered to the desired location, then is released. The tapered waist of the device not only ensures its self-centricity but also can reduce the probability of bad occlusion effect resulting from selection error. The left disc 1, which comprises skeletons and membranes, can decrease metal surface areas, thereby decreasing thrombus formation as well as harmful elements. The two discs are both individual components and can deploy completely after release of the occlusion device, and this can avoid forming cucurbit shape and increase the reliability of the desired occlusion.
FIG. 12 and FIG. 13 illustrate the deployment process of an FPO occluder and an ASD occluder during operation respectively. Moreover, the occluder has excellent self-centricity because the right disc 21 is close to the left disc 1.
The present invention is also suitable for treating PDA and VSD etc. The only difference from above other occluders is that the metal mesh of the PDA occluder of the present invention will not form a disc, but a “waist”.
Although the description above contains many specificities, these should not be construed as limiting the scope of the invention but as merely providing illustrations of some of the presently preferred embodiments of this invention. Thus the scope of the invention should be determined by the appended claims and their legal equivalents, rather than by the examples given.

Claims (17)

1. A heart septal defect occlusion device, comprising:
a right disc made from an interwoven metal mesh, the metal mesh having a plurality of openings;
a left disc comprising at least two skeletons that are covered by a membrane, with each skeleton passing through some openings of the metal mesh to interlock the right and left discs, wherein the left disc is different from the right disc, wherein each skeleton has a U-shaped middle segment, with the skeletons forming a left disc plane after being assembled together, with the left disc plane covered by the membrane;
wherein a portion of the right disc lies in the left disc plane, with the U-shaped middle segments interlocked with the metal mesh of the right disc; and
wherein the right and left discs are individual components that can deploy completely after releasing to avoid forming a cucurbit shape.
2. The device of claim 1, wherein the depth of the U-shaped segments are different for each of the skeletons so that the skeletons form the plane after being interlocked together.
3. The device of claim 2, wherein the left disc is made from at least two radial skeletons.
4. The device of claim 3, wherein the skeletons define two sides, and the skeletons are covered with membranes on both sides.
5. The device of claim 1 wherein the left disc is fixed by a connector.
6. The device of claim 1, wherein the right disc is fixed by a tip or joint.
7. The device of claim 6, wherein the skeletons pass through some openings of the metal mesh near the tip or joint.
8. The device of claim 7, wherein the skeletons overlap each other by passing through some openings of the metal mesh near the tip or joint.
9. The device of claim 1, wherein the membrane is made of biocompatible materials.
10. The device of claim 1, wherein the skeletons are made of a shape-memory material.
11. The device of claim 3, wherein each skeleton has two ends, with each end being spherical.
12. A heart septal defect occlusion device, comprising:
a right disc made from an interwoven metal mesh, the metal mesh having a plurality of openings;
a tip or joint positioned near the center of the right disc;
a left disc comprising at least two skeletons that are covered by a membrane, with each skeleton passing through some openings of the metal mesh near the tip or joint to interlock the right and left discs, each skeleton having two ends, with each end being spherical; and
wherein each skeleton has a U-shaped middle segment, with the depth of the U-shaped middle section being different for each of the skeletons so that the skeletons form a left disc plane after being interlocked together, with the left disc plane covered by the membrane, and wherein the left disc is different from the right disc;
wherein a portion of the right disc lies in the left disc plane, with the U-shaped middle segments interlocked with the metal mesh of the right disc; and
wherein the right and left discs are individual components that can deploy completely after releasing to avoid forming a cucurbit shape.
13. The device of claim 12, wherein the membrane is made of biocompatible materials.
14. The device of claim 13, wherein the skeletons are made of a shape-memory material.
15. A heart septal defect occlusion device, comprising:
a right disc comprising a metal mesh that has a plurality of openings, the metal mesh made from a tubular metal mesh that has been formed and then inserted into a mold for heat treatment; and
a left disc comprising at least two skeletons that are covered by a membrane, with each skeleton passing through some openings of the metal mesh to interlock the right and left discs, wherein the left disc is different from the right disc;
wherein the right and left discs are individual components that can deploy completely after releasing to avoid forming a cucurbit shape.
16. The device of claim 15, wherein the tubular metal mesh is laser carved.
17. The device of claim 15, wherein the tubular metal mesh is woven.
US11/307,178 2005-01-28 2006-01-26 Heart septal defect occlusion devices with adjustable length tether adapting to the unique anatomy of the patient Active 2027-10-29 US7828818B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/927,194 US8366743B2 (en) 2005-01-28 2010-11-08 Heart septal defect occlusion device

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200510032924 2005-01-28
CN200510032924.0 2005-01-28
CNB2005100329240A CN100389732C (en) 2005-01-28 2005-01-28 Heart septal defect stopper with self regulating function

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/927,194 Continuation-In-Part US8366743B2 (en) 2005-01-28 2010-11-08 Heart septal defect occlusion device

Publications (2)

Publication Number Publication Date
US20060200196A1 US20060200196A1 (en) 2006-09-07
US7828818B2 true US7828818B2 (en) 2010-11-09

Family

ID=36843434

Family Applications (1)

Application Number Title Priority Date Filing Date
US11/307,178 Active 2027-10-29 US7828818B2 (en) 2005-01-28 2006-01-26 Heart septal defect occlusion devices with adjustable length tether adapting to the unique anatomy of the patient

Country Status (2)

Country Link
US (1) US7828818B2 (en)
CN (1) CN100389732C (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069220A (en) * 2016-03-11 2018-12-21 Cerus血管内设备有限公司 plugging device
US11284901B2 (en) 2014-04-30 2022-03-29 Cerus Endovascular Limited Occlusion device
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods
US11471162B2 (en) 2015-12-07 2022-10-18 Cerus Endovascular Limited Occlusion device
US11517319B2 (en) 2017-09-23 2022-12-06 Universität Zürich Medical occluder device
US11812971B2 (en) 2017-08-21 2023-11-14 Cerus Endovascular Limited Occlusion device
US11944315B2 (en) 2019-09-26 2024-04-02 Universität Zürich Left atrial appendage occlusion devices

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617205B2 (en) 2007-02-01 2013-12-31 Cook Medical Technologies Llc Closure device
WO2008094691A2 (en) * 2007-02-01 2008-08-07 Cook Incorporated Closure device and method for occluding a bodily passageway
WO2008094706A2 (en) 2007-02-01 2008-08-07 Cook Incorporated Closure device and method of closing a bodily opening
US8734483B2 (en) * 2007-08-27 2014-05-27 Cook Medical Technologies Llc Spider PFO closure device
CN101449986B (en) * 2007-11-28 2011-08-31 王涛 Obturator of aorta ductus arteriosus
CN101966092B (en) * 2010-09-16 2012-10-10 先健科技(深圳)有限公司 Medical plugging device
EP2627265B8 (en) 2010-10-15 2019-02-20 Cook Medical Technologies LLC Occlusion device for blocking fluid flow through bodily passages
CN102440810B (en) * 2011-01-28 2014-02-12 先健科技(深圳)有限公司 Heart defect amplatzer
WO2013120082A1 (en) 2012-02-10 2013-08-15 Kassab Ghassan S Methods and uses of biological tissues for various stent and other medical applications
CN104905829B (en) * 2013-02-04 2018-07-27 先健科技(深圳)有限公司 A kind of plugging device of the flat disk with included-angle-changeable
EP2953580A2 (en) 2013-02-11 2015-12-16 Cook Medical Technologies LLC Expandable support frame and medical device
US11911258B2 (en) * 2013-06-26 2024-02-27 W. L. Gore & Associates, Inc. Space filling devices
CN106333723B (en) * 2015-07-09 2020-09-29 先健科技(深圳)有限公司 Ventricular septum and method of making same
CN108926370B (en) * 2017-05-23 2024-04-16 杭州德诺电生理医疗科技有限公司 Left auricle plugging device capable of improving sealing effect and assembling method thereof
CN109758194B (en) * 2019-02-27 2020-06-26 武汉唯柯医疗科技有限公司 Atrial septum plugging device

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3874388A (en) 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US5451235A (en) * 1991-11-05 1995-09-19 C.R. Bard, Inc. Occluder and method for repair of cardiac and vascular defects
US5683411A (en) * 1994-04-06 1997-11-04 William Cook Europe A/S Medical article for implantation into the vascular system of a patient
US5944738A (en) * 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
CN2430113Y (en) 2000-08-28 2001-05-16 曾国洪 Disposable abnormal path block device in heart and blood vessel
CN2566817Y (en) 2002-09-12 2003-08-20 深圳市先健科技股份有限公司 Stopper for ventricular septal defect
CN1442122A (en) 2002-03-06 2003-09-17 深圳市先健科技股份有限公司 Ventricular septal defect blocking apparatus and its making method
US6712836B1 (en) * 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
US20040117032A1 (en) 1993-02-22 2004-06-17 Roth Alex T. Devices for less-invasive intracardiac interventions
CN2661130Y (en) 2003-06-12 2004-12-08 深圳市先健科技股份有限公司 Total integument heart septal defect blockage
US20050065547A1 (en) * 2003-09-18 2005-03-24 Cardia, Inc. ASD closure device with self centering arm network
WO2005034738A2 (en) 2003-10-10 2005-04-21 Proximare, Inc. Patent foramen ovale (pfo) closure devices, delivery apparatus and related methods and systems
US7658748B2 (en) * 2003-09-23 2010-02-09 Cardia, Inc. Right retrieval mechanism

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3671404B2 (en) * 1995-01-27 2005-07-13 ニプロ株式会社 Atrial septal defect prosthesis and catheter for closing an atrial septal defect using the prosthesis

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3874388A (en) 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US5451235A (en) * 1991-11-05 1995-09-19 C.R. Bard, Inc. Occluder and method for repair of cardiac and vascular defects
US20040117032A1 (en) 1993-02-22 2004-06-17 Roth Alex T. Devices for less-invasive intracardiac interventions
US5683411A (en) * 1994-04-06 1997-11-04 William Cook Europe A/S Medical article for implantation into the vascular system of a patient
US5944738A (en) * 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
US6712836B1 (en) * 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
CN2430113Y (en) 2000-08-28 2001-05-16 曾国洪 Disposable abnormal path block device in heart and blood vessel
CN1442122A (en) 2002-03-06 2003-09-17 深圳市先健科技股份有限公司 Ventricular septal defect blocking apparatus and its making method
CN2566817Y (en) 2002-09-12 2003-08-20 深圳市先健科技股份有限公司 Stopper for ventricular septal defect
CN2661130Y (en) 2003-06-12 2004-12-08 深圳市先健科技股份有限公司 Total integument heart septal defect blockage
US20050065547A1 (en) * 2003-09-18 2005-03-24 Cardia, Inc. ASD closure device with self centering arm network
US7144410B2 (en) * 2003-09-18 2006-12-05 Cardia Inc. ASD closure device with self centering arm network
US7658748B2 (en) * 2003-09-23 2010-02-09 Cardia, Inc. Right retrieval mechanism
WO2005034738A2 (en) 2003-10-10 2005-04-21 Proximare, Inc. Patent foramen ovale (pfo) closure devices, delivery apparatus and related methods and systems

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11284901B2 (en) 2014-04-30 2022-03-29 Cerus Endovascular Limited Occlusion device
US11389174B2 (en) 2014-04-30 2022-07-19 Cerus Endovascular Limited Occlusion device
US11471162B2 (en) 2015-12-07 2022-10-18 Cerus Endovascular Limited Occlusion device
CN109069220A (en) * 2016-03-11 2018-12-21 Cerus血管内设备有限公司 plugging device
US11648013B2 (en) 2016-03-11 2023-05-16 Cerus Endovascular Limited Occlusion device
US11812971B2 (en) 2017-08-21 2023-11-14 Cerus Endovascular Limited Occlusion device
US11517319B2 (en) 2017-09-23 2022-12-06 Universität Zürich Medical occluder device
US11944315B2 (en) 2019-09-26 2024-04-02 Universität Zürich Left atrial appendage occlusion devices
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods

Also Published As

Publication number Publication date
US20060200196A1 (en) 2006-09-07
CN100389732C (en) 2008-05-28
CN1810219A (en) 2006-08-02

Similar Documents

Publication Publication Date Title
US7828818B2 (en) Heart septal defect occlusion devices with adjustable length tether adapting to the unique anatomy of the patient
US10624619B2 (en) Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US20240016488A1 (en) Occlusion Device And Method For Its Manufacture
AU2005201132B2 (en) Multi-layer braided structures for occluding vascular defects
EP1011469B1 (en) Percutaneous catheter directed occlusion devices
EP1651116B1 (en) Tubular patent foramen ovale (pfo) closure device with catch system
EP1842490B1 (en) Occlusion devices for treating of congenital heart disease with auto-adjusting function
RU2446773C2 (en) Multilayered woven constructions for occlusion of vascular defects
EP2004065B1 (en) Tubular patent foramen ovale (pfo) closure device with catch system
US8366743B2 (en) Heart septal defect occlusion device

Legal Events

Date Code Title Description
AS Assignment

Owner name: LIFETECH SCIENTIFIC INC., CHINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZANG, SHIXIAN;ZI, ERIC;LV, SHIWEN;AND OTHERS;REEL/FRAME:017068/0438

Effective date: 20060124

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552)

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 12